AAAAAA

   
Results: 1-25 | 26-41 |
Results: 26-41/41
Down-regulation of CD98 in melphalan-resistant myeloma cells with reduced drug uptake
Authors: Harada, N Nagasaki, A Hata, H Matsuzaki, H Matsuno, F Mitsuya, H
Citation: N. Harada et al., Down-regulation of CD98 in melphalan-resistant myeloma cells with reduced drug uptake, ACT HAEMAT, 103(3), 2000, pp. 144-151
Characterization of human immunodeficiency virus type 1 strains resistant to the non-nucleoside reverse transcriptase inhibitor RD4-2217
Authors: Fujiwara, M Kodama, EN Okamoto, M Tokuhisa, K Ide, T Hanasaki, Y Katsuura, K Takayama, H Aimi, N Mitsuya, H Shigeta, S Konno, K Yokota, T Baba, M
Citation: M. Fujiwara et al., Characterization of human immunodeficiency virus type 1 strains resistant to the non-nucleoside reverse transcriptase inhibitor RD4-2217, ANTIVIR CHE, 10(6), 1999, pp. 315-320
Inhibition of human immunodeficiency virus replication by RD6-Y664, a novel benzylhydroxylamine derivative
Authors: Okamoto, M Fujiwara, M Kodama, E Yamamoto, O Shigeta, S Mitsuya, H Konno, K Yokota, T Baba, M
Citation: M. Okamoto et al., Inhibition of human immunodeficiency virus replication by RD6-Y664, a novel benzylhydroxylamine derivative, ANTIVIR CHE, 10(2), 1999, pp. 71-77
Absence of Kaposi's sarcoma-associated herpesvirus (KSHV) in bone marrow cells from Japanese myeloma patients
Authors: Harada, N Hata, N Matsuno, F Sonoki, T Kuribayashi, N Matsuzaki, H Mitsuya, H
Citation: N. Harada et al., Absence of Kaposi's sarcoma-associated herpesvirus (KSHV) in bone marrow cells from Japanese myeloma patients, LEUKEMIA, 13(9), 1999, pp. 1465-1466
Detection of inducible nitric oxide synthase (iNOS) mRNA by RT-PCR in ATL patients and HTLV-I infected cell lines: clinical features and apoptosis byNOS inhibitor
Authors: Sonoki, T Matsuzaki, H Nagasaki, A Hata, H Yoshida, M Matsuoka, M Kuribayashi, N Kimura, T Harada, N Takatsuki, K Mitsuya, H Mori, M
Citation: T. Sonoki et al., Detection of inducible nitric oxide synthase (iNOS) mRNA by RT-PCR in ATL patients and HTLV-I infected cell lines: clinical features and apoptosis byNOS inhibitor, LEUKEMIA, 13(5), 1999, pp. 713-718
A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infection
Authors: Humphrey, RW Wyvill, KM Nguyen, BY Shay, LE Kohler, DR Steinberg, SM Ueno, T Fukasawa, T Shintani, M Hayashi, H Mitsuya, H Yarchoan, R
Citation: Rw. Humphrey et al., A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infection, ANTIVIR RES, 41(1), 1999, pp. 21-33
In vitro anti-human immunodeficiency virus activities of Z- and E-methylenecyclopropane nucleoside analogues and their phosphoro-L-alaninate diesters
Authors: Uchida, H Kodama, EN Yoshimura, K Maeda, Y Kosalaraksa, P Maroun, V Qiu, YL Zemlicka, J Mitsuya, H
Citation: H. Uchida et al., In vitro anti-human immunodeficiency virus activities of Z- and E-methylenecyclopropane nucleoside analogues and their phosphoro-L-alaninate diesters, ANTIM AG CH, 43(6), 1999, pp. 1487-1490
In vitro induction of human immunodeficiency virus type 1 variants resistant to phosphoralaninate prodrugs of Z-methylenecyclopropane nucleoside analogues
Authors: Yoshimura, K Feldman, R Kodama, E Kavlick, MF Qiu, YL Zemlicka, J Mitsuya, H
Citation: K. Yoshimura et al., In vitro induction of human immunodeficiency virus type 1 variants resistant to phosphoralaninate prodrugs of Z-methylenecyclopropane nucleoside analogues, ANTIM AG CH, 43(10), 1999, pp. 2479-2483
JE-2147: A dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1
Authors: Yoshimura, K Kato, R Yusa, K Kavlick, MF Maroun, V Nguyen, A Mimoto, T Ueno, T Shintani, M Falloon, J Masur, H Hayashi, H Erickson, J Mitsuya, H
Citation: K. Yoshimura et al., JE-2147: A dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1, P NAS US, 96(15), 1999, pp. 8675-8680
Suppression of replication of multidrug-resistant HIV type 1 variants by combinations of thymidylate synthase inhibitors with zidovudine or stavudine
Authors: Gao, WY Johns, DG Tanaka, M Mitsuya, H
Citation: Wy. Gao et al., Suppression of replication of multidrug-resistant HIV type 1 variants by combinations of thymidylate synthase inhibitors with zidovudine or stavudine, MOLEC PHARM, 55(3), 1999, pp. 535-540
Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an in vitro competitive HIV-1 replication assay
Authors: Kosalaraksa, P Kavlick, MF Maroun, V Le, R Mitsuya, H
Citation: P. Kosalaraksa et al., Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an in vitro competitive HIV-1 replication assay, J VIROLOGY, 73(7), 1999, pp. 5356-5363
Conserved cysteines of the human immunodeficiency virus type 1 protease are involved in regulation of polyprotein processing and viral maturation of immature virions
Authors: Davis, DA Yusa, K Gillim, LA Newcomb, FM Mitsuya, H Yarchoan, R
Citation: Da. Davis et al., Conserved cysteines of the human immunodeficiency virus type 1 protease are involved in regulation of polyprotein processing and viral maturation of immature virions, J VIROLOGY, 73(2), 1999, pp. 1156-1164
Expression of PRAD1 cyclin D1 in plasma cell malignancy: incidence and prognostic aspects
Authors: Sonoki, T Hata, H Kuribayashi, N Yoshida, M Harada, N Nagasaki, A Kimura, T Matsuno, F Mitsuya, H Matsuzaki, H
Citation: T. Sonoki et al., Expression of PRAD1 cyclin D1 in plasma cell malignancy: incidence and prognostic aspects, BR J HAEM, 104(3), 1999, pp. 614-617
Chemokine and chemokine receptor gene variants and risk of non-Hodgkin's lymphoma in human immunodeficiency virus-1-infected individuals
Authors: Rabkin, CS Yang, Q Goedert, JJ Nguyen, G Mitsuya, H Sei, S
Citation: Cs. Rabkin et al., Chemokine and chemokine receptor gene variants and risk of non-Hodgkin's lymphoma in human immunodeficiency virus-1-infected individuals, BLOOD, 93(6), 1999, pp. 1838-1842
A plasma cell leukemia patient showing bialleic 14q translocations: t(2;14) and t(11;14)
Authors: Sonoki, T Matsuzaki, H Satterwhite, E Nakazawa, N Hata, H Tucker, PW Taniwaki, M Kuribayashi, N Harada, N Matsuno, F Mitsuya, H
Citation: T. Sonoki et al., A plasma cell leukemia patient showing bialleic 14q translocations: t(2;14) and t(11;14), ACT HAEMAT, 101(4), 1999, pp. 197-201
Amplification and overexpression of the PRAD1 Cyclin D1 gene in a multiplemyeloma cell line
Authors: Sonoki, T Nakazawa, N Hata, H Taniwaki, M Nagasaki, A Seto, M Yoshida, M Kuribayashi, N Kimura, T Harada, N Mitsuya, H Matsuzaki, H
Citation: T. Sonoki et al., Amplification and overexpression of the PRAD1 Cyclin D1 gene in a multiplemyeloma cell line, INT J HEMAT, 68(4), 1998, pp. 459-461
Risultati: 1-25 | 26-41 |